Billionaire Stanley Druckenmiller Allocates $1,027,090,408 To Three Under-The-Radar Stocks

Billionaire Stanley Druckenmiller has now allocated more than a billion dollars to three under-the-radar equities.

New filings show Druckenmiller’s Duquesne Family Office is betting big on stocks in the tech and healthcare sectors.

As of Q1 2025, the firm’s largest position is in Natera Inc. (NTRA), a tech firm specializing in genetic testing for the early detection of hereditary conditions such as cancer. Data shows Duquesne now owns 3.402 million NTRA shares worth about $521.48 million.

The firm also holds a major position in Teva Pharmaceutical Industries (TEVA), an Israel-based manufacturer of generic medicines. According to the filing, Duquesne has accumulated 14.879 million shares of TEVA worth about $252.955 million.

Druckenmiller has also invested heavily in the South Korean e-commerce giant Coupang Inc. (CPNG). The firm holds more than 9.3 million shares of CPNG worth roughly $252.659 million.

All in all, Duquesne Family Office owns more than $1.02 billion worth of shares in NTRA, TEVA and CPNG, representing 33 of the firm’s $3.06 billion portfolio.

In addition to NTRA, TEVA and CPNG, Druckenmiller’s top holdings as of Q1 of this year include Woodward Inc. (WWD) worth $226.13 million, Philip Morris International (PM) worth $193.67 million and Coherent (COHR) worth $175.27 million.

Meanwhile, the firm reduced its stake in Seagate Technology (STX), Skechers USA (SKX), United Airlines (UAL) and SLM Corp (SLM) in Q1 2025.